Abstract
Background Seborrheic keratoses are the most common skin lesions known to contain small white or yellow structures called milia-like cysts (MLCs). Varied appearances can sometimes make it difficult to differentiate benign lesions from malignant lesions such as melanoma, the deadliest form of skin cancer found in humans. Objective the purpose of this study was to determine the statistical occurrence of MLCs in benign vs. malignant lesions. Methods a medical student with 10 months experience in examining approximately 1000 dermoscopy images and a dermoscopy-naïve observer analyzed contact non-polarized dermoscopy images of 221 malignant melanomas and 175 seborrheic keratoses for presence of MLCs. Results the observers found two different types of MLCs present: large ones described as cloudy and smaller ones described as starry. Starry MLCs were found to be prevalent in both seborrheic keratoses and melanomas. Cloudy MLCs, however, were found to have 99.1% specificity for seborrheic keratoses among this group of seborrheic keratoses and melanomas. Conclusion Cloudy MLCs can be a useful tool for differentiating between seborrheic keratoses and melanomas. © 2010 the Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.
Recommended Citation
S. M. Stricklin et al., "Cloudy and Starry Milia-like Cysts: How Well Do They Distinguish Seborrheic Keratoses from Malignant Melanomas?," Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 10, pp. 1222 - 1224, Wiley, Oct 2011.
The definitive version is available at https://doi.org/10.1111/j.1468-3083.2010.03920.x
Department(s)
Chemistry
Publication Status
Full Access
Keywords and Phrases
melanoma; milia-like Cyst; seborrheic Keratosis
International Standard Serial Number (ISSN)
1468-3083; 0926-9959
Document Type
Article - Journal
Document Version
Citation
File Type
text
Language(s)
English
Rights
© 2024 Wiley, All rights reserved.
Publication Date
01 Oct 2011
PubMed ID
21923811
Comments
National Cancer Institute, Grant R44CA101639